Olatec Therapeutics
Daniel Yadegar is currently a Clinical Advisor at Olatec Therapeutics. Daniel previously worked as a Clinical Consultant at Holistic Integrative Health (HIH).
Daniel Yadegar's educational career includes receiving a Doctor of Medicine (M.D.) from Joan & Sanford I. Weill Medical College of Cornell University, an AB with Honors in Psychology from Harvard University, and a BA in Psychology from Harvard University.
This person is not in the org chart
This person is not in any offices
Olatec Therapeutics
Olatec is a privately held biopharmaceutical company developing a platform of safe, oral NLRP3 antagonist therapeutics, to treat and prevent a broad spectrum of acute and chronic inflammatory diseases that are known to be mediated by Interleukin-1 (IL-1), including: arthritis, heart failure, asthma, Alzheimer’s disease, multiple sclerosis, type-2 diabetes, melanoma and breast cancers, among others.